Your browser doesn't support javascript.
loading
MITOL/MARCH5 determines the susceptibility of cardiomyocytes to doxorubicin-induced ferroptosis by regulating GSH homeostasis.
Kitakata, Hiroki; Endo, Jin; Matsushima, Hirokazu; Yamamoto, Shoichi; Ikura, Hidehiko; Hirai, Akeo; Koh, Seien; Ichihara, Genki; Hiraide, Takahiro; Moriyama, Hidenori; Shirakawa, Kohsuke; Goto, Shinichi; Katsumata, Yoshinori; Anzai, Atsushi; Kataoka, Masaharu; Tokuyama, Takeshi; Ishido, Satoshi; Yanagi, Shigeru; Fukuda, Keiichi; Sano, Motoaki.
Afiliación
  • Kitakata H; Department of Cardiology, Keio University School of Medicine, Tokyo, Japan.
  • Endo J; Department of Cardiology, Keio University School of Medicine, Tokyo, Japan. Electronic address: jinendo@keio.jp.
  • Matsushima H; Department of Cardiology, Keio University School of Medicine, Tokyo, Japan.
  • Yamamoto S; Department of Cardiology, Keio University School of Medicine, Tokyo, Japan.
  • Ikura H; Department of Cardiology, Keio University School of Medicine, Tokyo, Japan.
  • Hirai A; Department of Cardiology, Keio University School of Medicine, Tokyo, Japan.
  • Koh S; Department of Cardiology, Keio University School of Medicine, Tokyo, Japan.
  • Ichihara G; Department of Cardiology, Keio University School of Medicine, Tokyo, Japan.
  • Hiraide T; Department of Cardiology, Keio University School of Medicine, Tokyo, Japan.
  • Moriyama H; Department of Cardiology, Keio University School of Medicine, Tokyo, Japan.
  • Shirakawa K; Department of Cardiology, Keio University School of Medicine, Tokyo, Japan.
  • Goto S; Department of Cardiology, Keio University School of Medicine, Tokyo, Japan.
  • Katsumata Y; Department of Cardiology, Keio University School of Medicine, Tokyo, Japan.
  • Anzai A; Department of Cardiology, Keio University School of Medicine, Tokyo, Japan.
  • Kataoka M; Department of Cardiology, Keio University School of Medicine, Tokyo, Japan.
  • Tokuyama T; Laboratory of Molecular Biochemistry, School of Life Science. Tokyo University of Pharmacy and Life Sciences, Tokyo, Japan.
  • Ishido S; Department of Microbiology, Hyogo College of Medicine, Nishinomiya, Japan.
  • Yanagi S; Laboratory of Molecular Biochemistry, School of Life Science. Tokyo University of Pharmacy and Life Sciences, Tokyo, Japan.
  • Fukuda K; Department of Cardiology, Keio University School of Medicine, Tokyo, Japan.
  • Sano M; Department of Cardiology, Keio University School of Medicine, Tokyo, Japan.
J Mol Cell Cardiol ; 161: 116-129, 2021 12.
Article en En | MEDLINE | ID: mdl-34390730
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 2_ODS3 / 6_ODS3_enfermedades_notrasmisibles Problema de salud: 2_muertes_prevenibles / 6_cardiovascular_diseases Asunto principal: Doxorrubicina / Proteínas Mitocondriales / Miocitos Cardíacos / Ubiquitina-Proteína Ligasas / Glutatión / Cardiomiopatías Límite: Animals / Humans / Male Idioma: En Revista: J Mol Cell Cardiol Año: 2021 Tipo del documento: Article País de afiliación: Japón
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 2_ODS3 / 6_ODS3_enfermedades_notrasmisibles Problema de salud: 2_muertes_prevenibles / 6_cardiovascular_diseases Asunto principal: Doxorrubicina / Proteínas Mitocondriales / Miocitos Cardíacos / Ubiquitina-Proteína Ligasas / Glutatión / Cardiomiopatías Límite: Animals / Humans / Male Idioma: En Revista: J Mol Cell Cardiol Año: 2021 Tipo del documento: Article País de afiliación: Japón